vimarsana.com
Home
Live Updates
Pneumococcal Vaccine Label Adds Injection-Site Risk : vimarsana.com
Pneumococcal Vaccine Label Adds Injection-Site Risk
After reports of necrosis at the injection site after the 23-valent pneumococcal vaccine, an FDA investigation has concluded that the benefits of the vaccine outweigh the risks.
Related Keywords
,
Research Letter ,
Centers For Disease ,
Drug Administration ,
Brendan Day ,
Biologics Evaluation ,
Disease Control ,
Vaccine Adverse Event Reporting System ,
Post Marketing Experience ,
Patient Safety ,
Pneumococcal Vaccine ,
Vaccine ,
Adverse Effects Of Vaccines ,
Adverse Effects ,
Side Effects ,
Rare Diseases ,
Immunizations ,
Vaccination ,
Us Food And Drug Administration ,
Nited States Food And Drug Administration ,
Fda ,
vimarsana.com © 2020. All Rights Reserved.